Estrogen modulation of IFNgamma-mediated conditions and diseases

Details for Australian Patent Application No. 2005247453 (hide)

Owner Cedars-Sinai Medical Center

Inventors Targan, Stephan R.; Gonsky, Rivkah

Agent Freehills

Pub. Number AU-B-2005247453

PCT Pub. Number WO2005/115469

Priority 60/573,872 24.05.04 US

Filing date 24 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 3 April 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 35/26 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Lymph

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/115469 Priority application(s): WO2005/115469

3 April 2008 Application Accepted

  Published as AU-B-2005247453

7 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247460-Peptide conjugated, inosine-substituted antisense oligomer compound and method

2005247441-Animal instrumentation